Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Dyslipidemia | Research article

The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease

Authors: Nejc Piko, Sebastjan Bevc, Radovan Hojs, Franjo Husam Naji, Robert Ekart

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Introduction

Functional changes in peripheral arterial disease (PAD) could play a role in higher cardiovascular risk in these patients.

Methods

123 patients who underwent elective coronary angiography were included. Ankle-brachial index (ABI) was measured and arterial stiffness parameters were derived with applanation tonometry.

Results

6 patients (4.9%) had a previously known PAD (Rutherford grade I). Mean ABI was 1.04 ± 0.12, mean subendocardial viability ratio (SEVR) 166.6 ± 32.7% and mean carotid-femoral pulse wave velocity (cfPWV) 10.3 ± 2.4 m/s. Most of the patients (n = 81, 65.9%) had coronary artery disease (CAD). There was no difference in ABI among different degrees of CAD. Patients with zero- and three-vessel CAD had significantly lower values of SEVR, compared to patients with one- and two-vessel CAD (159.5 ± 32.9%/158.1 ± 31.5% vs 181.0 ± 35.2%/166.8 ± 27.8%; p = 0.048). No significant difference was observed in cfPWV values. Spearman's correlation test showed an important correlation between ABI and SEVR (r = 0.196; p = 0.037) and between ABI and cfPWV (r = − 0.320; p ≤ 0.001). Multiple regression analysis confirmed an association between cfPWV and ABI (β = − 0.210; p = 0.003), cfPWV and mean arterial pressure (β = 0.064; p < 0.001), cfPWV and age (β = 0.113; p < 0.001) and between cfPWV and body mass index (BMI (β = − 0.195; p = 0.028), but not with arterial hypertension, dyslipidemia, diabetes mellitus or smoking status. SEVR was not statistically significantly associated with ABI using the same multiple regression model.

Conclusion

Reduced ABI was associated with increased cfPWV, but not with advanced CAD or decreased SEVR.
Literature
1.
go back to reference Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol Med. 2017;23(4):332–47.PubMedCrossRef Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol Med. 2017;23(4):332–47.PubMedCrossRef
2.
go back to reference Piko N, Ekart R, Bevc S, Hojs R. Atherosclerosis, epigenetic modifications, and arterial stiffness. Acta Med Biotech. 2017;10(2):10–7. Piko N, Ekart R, Bevc S, Hojs R. Atherosclerosis, epigenetic modifications, and arterial stiffness. Acta Med Biotech. 2017;10(2):10–7.
4.
go back to reference Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911.PubMedPubMedCentralCrossRef Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911.PubMedPubMedCentralCrossRef
5.
go back to reference Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–146.PubMed Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–146.PubMed
6.
go back to reference McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcom GT, Herderick EE, et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000;102(4):374–9.PubMedCrossRef McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcom GT, Herderick EE, et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000;102(4):374–9.PubMedCrossRef
7.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.PubMedCrossRef Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.PubMedCrossRef
8.
go back to reference Letonja M, Petrovič D, Letonja MŠ, Starčević JN. Ultrasonographic and classical risk factors of carotid atherosclerosis in patients with type-2 diabetes mellitus. Acta Med Biotech. 2013;6(1):33–44. Letonja M, Petrovič D, Letonja MŠ, Starčević JN. Ultrasonographic and classical risk factors of carotid atherosclerosis in patients with type-2 diabetes mellitus. Acta Med Biotech. 2013;6(1):33–44.
9.
go back to reference Bevc S, Purg D, Turnšek N, Hren M, Hojs N, Zorman T, et al. Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients. Ther Apher Dial. 2013;17(4):373–7.PubMedCrossRef Bevc S, Purg D, Turnšek N, Hren M, Hojs N, Zorman T, et al. Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients. Ther Apher Dial. 2013;17(4):373–7.PubMedCrossRef
10.
go back to reference Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931–41.PubMedPubMedCentralCrossRef Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931–41.PubMedPubMedCentralCrossRef
11.
go back to reference Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D, Hiatt WR. Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options. J Am Coll Cardiol. 2016;67(11):1338–57.PubMedCrossRef Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D, Hiatt WR. Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options. J Am Coll Cardiol. 2016;67(11):1338–57.PubMedCrossRef
12.
go back to reference Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.PubMedCrossRef Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.PubMedCrossRef
13.
go back to reference Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, et al. Non-coronary atherosclerosis. Eur Heart J. 2014;35(17):1112–9.PubMedCrossRef Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, et al. Non-coronary atherosclerosis. Eur Heart J. 2014;35(17):1112–9.PubMedCrossRef
14.
go back to reference Catalano M, Scandale G, Carzaniga G, Cinquini M, Minola M, Antoniazzi V, et al. Aortic augmentation index in patients with peripheral arterial disease. J Clin Hypertens (Greenwich). 2014;16(11):782–7.CrossRef Catalano M, Scandale G, Carzaniga G, Cinquini M, Minola M, Antoniazzi V, et al. Aortic augmentation index in patients with peripheral arterial disease. J Clin Hypertens (Greenwich). 2014;16(11):782–7.CrossRef
15.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-654.PubMedCrossRef Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-654.PubMedCrossRef
16.
go back to reference Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–906.PubMedCrossRef Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–906.PubMedCrossRef
17.
go back to reference Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–33.PubMedPubMedCentralCrossRef Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–33.PubMedPubMedCentralCrossRef
18.
go back to reference Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463–9.PubMedCrossRef Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463–9.PubMedCrossRef
19.
go back to reference Scandale G, Dimitrov G, Recchia M, Carzaniga G, Minola M, Perilli E, et al. Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease. J Clin Hypertens (Greenwich). 2018;20(3):478–84.CrossRef Scandale G, Dimitrov G, Recchia M, Carzaniga G, Minola M, Perilli E, et al. Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease. J Clin Hypertens (Greenwich). 2018;20(3):478–84.CrossRef
20.
go back to reference Nürnberger J, Dammer S, Opazo Saez A, Philipp T, Schäfers RF. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens. 2003;17(3):153–8.PubMedCrossRef Nürnberger J, Dammer S, Opazo Saez A, Philipp T, Schäfers RF. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens. 2003;17(3):153–8.PubMedCrossRef
21.
go back to reference Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse wave analysis by applanation tonometry for the measurement of arterial stiffness. Open Cardiovasc Med J. 2016;10:188–95.PubMedPubMedCentralCrossRef Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse wave analysis by applanation tonometry for the measurement of arterial stiffness. Open Cardiovasc Med J. 2016;10:188–95.PubMedPubMedCentralCrossRef
22.
go back to reference Mosimann K, Jacomella V, Thalhammer C, Meier TO, Kohler M, Amann-Vesti B, et al. Severity of peripheral arterial disease is associated with aortic pressure augmentation and subendocardial viability ratio. J Clin Hypertens (Greenwich). 2012;14(12):855–60.CrossRef Mosimann K, Jacomella V, Thalhammer C, Meier TO, Kohler M, Amann-Vesti B, et al. Severity of peripheral arterial disease is associated with aortic pressure augmentation and subendocardial viability ratio. J Clin Hypertens (Greenwich). 2012;14(12):855–60.CrossRef
23.
go back to reference Ekart R, Bevc S, Hojs N, Knehtl M, Dvoršak B, Hojs R. Albuminuria is associated with subendocardial viability ratio in chronic kidney disease patients. Kidney Blood Press Res. 2015;40(6):565–74.PubMedCrossRef Ekart R, Bevc S, Hojs N, Knehtl M, Dvoršak B, Hojs R. Albuminuria is associated with subendocardial viability ratio in chronic kidney disease patients. Kidney Blood Press Res. 2015;40(6):565–74.PubMedCrossRef
24.
go back to reference Špan M, Geršak G, Millasseau SC, Meža M, Košir A. Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method. Vasc Health Risk Manag. 2016;12:305–11.PubMedPubMedCentralCrossRef Špan M, Geršak G, Millasseau SC, Meža M, Košir A. Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method. Vasc Health Risk Manag. 2016;12:305–11.PubMedPubMedCentralCrossRef
25.
go back to reference Vermeersch SJ, Rietzschel ER, De Buyzere ML, Van Bortel LM, Gillebert TC, Verdonck PR, et al. Distance measurements for the assessment of carotid to femoral pulse wave velocity. J Hypertens. 2009;27(12):2377–85.PubMedCrossRef Vermeersch SJ, Rietzschel ER, De Buyzere ML, Van Bortel LM, Gillebert TC, Verdonck PR, et al. Distance measurements for the assessment of carotid to femoral pulse wave velocity. J Hypertens. 2009;27(12):2377–85.PubMedCrossRef
26.
go back to reference Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184–9.PubMedCrossRef Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184–9.PubMedCrossRef
27.
go back to reference Gaszner B, Lenkey Z, Illyés M, Sárszegi Z, Horváth IG, Magyari B, et al. Comparison of aortic and carotid arterial stiffness parameters in patients with verified coronary artery disease. Clin Cardiol. 2012;35(1):26–31.PubMedCrossRef Gaszner B, Lenkey Z, Illyés M, Sárszegi Z, Horváth IG, Magyari B, et al. Comparison of aortic and carotid arterial stiffness parameters in patients with verified coronary artery disease. Clin Cardiol. 2012;35(1):26–31.PubMedCrossRef
28.
go back to reference Prskalo Z, Brizić I, Markota D, Markota I, Boban M, Tomic M, et al. Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:128.PubMedPubMedCentralCrossRef Prskalo Z, Brizić I, Markota D, Markota I, Boban M, Tomic M, et al. Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:128.PubMedPubMedCentralCrossRef
29.
go back to reference Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens. 2012;26(1):64–70.PubMedCrossRef Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens. 2012;26(1):64–70.PubMedCrossRef
30.
go back to reference Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34(5):1203–6.PubMedCrossRef Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34(5):1203–6.PubMedCrossRef
31.
go back to reference Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, et al. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke. 2012;43(2):543–4.PubMedCrossRef Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, et al. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke. 2012;43(2):543–4.PubMedCrossRef
32.
go back to reference Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657–63.PubMedCrossRef Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657–63.PubMedCrossRef
33.
go back to reference Upala S, Wirunsawanya K, Jaruvongvanich V, Sanguankeo A. Effects of statin therapy on arterial stiffness: a systematic review and meta-analysis of randomized controlled trial. Int J Cardiol. 2017;227:338–41.PubMedCrossRef Upala S, Wirunsawanya K, Jaruvongvanich V, Sanguankeo A. Effects of statin therapy on arterial stiffness: a systematic review and meta-analysis of randomized controlled trial. Int J Cardiol. 2017;227:338–41.PubMedCrossRef
34.
go back to reference Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43(2):176–81.PubMedCrossRef Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43(2):176–81.PubMedCrossRef
35.
go back to reference Laugesen E, Høyem P, Fleischer J, Kumarathas I, Knudsen ST, Hansen KW, et al. Reduced subendocardial viability ratio is associated with unfavorable cardiovascular risk profile in women with short duration of type 2 diabetes. Am J Hypertens. 2016;29(10):1165–72.PubMedCrossRef Laugesen E, Høyem P, Fleischer J, Kumarathas I, Knudsen ST, Hansen KW, et al. Reduced subendocardial viability ratio is associated with unfavorable cardiovascular risk profile in women with short duration of type 2 diabetes. Am J Hypertens. 2016;29(10):1165–72.PubMedCrossRef
36.
go back to reference Georgianos PI, Sarafidis PA, Lasaridis AN. Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients. Curr Vasc Pharmacol. 2015;13(2):229–38.PubMedCrossRef Georgianos PI, Sarafidis PA, Lasaridis AN. Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients. Curr Vasc Pharmacol. 2015;13(2):229–38.PubMedCrossRef
37.
go back to reference Zahner GJ, Gruendl MA, Spaulding KA, Schaller MS, Hills NK, Gasper WJ, et al. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry. J Vasc Surg. 2017;66(5):1518–26.PubMedPubMedCentralCrossRef Zahner GJ, Gruendl MA, Spaulding KA, Schaller MS, Hills NK, Gasper WJ, et al. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry. J Vasc Surg. 2017;66(5):1518–26.PubMedPubMedCentralCrossRef
38.
go back to reference Del Brutto OH, Mera RM, Sedler MJ, Gruen JA, Phelan KJ, Cusick EH, et al. The relationship between high pulse pressure and low ankle-brachial index. Potential utility in screening for peripheral artery disease in population-based studies. High Blood Press Cardiovasc Prev. 2015;22(3):275–80.PubMedCrossRef Del Brutto OH, Mera RM, Sedler MJ, Gruen JA, Phelan KJ, Cusick EH, et al. The relationship between high pulse pressure and low ankle-brachial index. Potential utility in screening for peripheral artery disease in population-based studies. High Blood Press Cardiovasc Prev. 2015;22(3):275–80.PubMedCrossRef
39.
go back to reference Rogers WJ, Hu YL, Coast D, Vido DA, Kramer CM, Pyeritz RE, et al. Age-associated changes in regional aortic pulse wave velocity. J Am Coll Cardiol. 2001;38(4):1123–9.PubMedCrossRef Rogers WJ, Hu YL, Coast D, Vido DA, Kramer CM, Pyeritz RE, et al. Age-associated changes in regional aortic pulse wave velocity. J Am Coll Cardiol. 2001;38(4):1123–9.PubMedCrossRef
40.
go back to reference Tang B, Luo F, Zhao J, Ma J, Tan I, Butlin M, et al. Relationship between body mass index and arterial stiffness in a health assessment Chinese population. Medicine (Baltimore). 2020;99(3):e18793.CrossRef Tang B, Luo F, Zhao J, Ma J, Tan I, Butlin M, et al. Relationship between body mass index and arterial stiffness in a health assessment Chinese population. Medicine (Baltimore). 2020;99(3):e18793.CrossRef
41.
go back to reference Rodrigues SL, Baldo MP, Lani L, Nogueira L, Mill JG, de Sa Cunha R. Body mass index is not independently associated with increased aortic stiffness in a Brazilian population. Am J Hypertens. 2012;25(10):1064–9.PubMedCrossRef Rodrigues SL, Baldo MP, Lani L, Nogueira L, Mill JG, de Sa Cunha R. Body mass index is not independently associated with increased aortic stiffness in a Brazilian population. Am J Hypertens. 2012;25(10):1064–9.PubMedCrossRef
42.
go back to reference Desamericq G, Tissot CM, Akakpo S, Tropeano AI, Millasseau S, Macquin-Mavier I. Carotid-femoral pulse wave velocity is not increased in obesity. Am J Hypertens. 2015;28(4):546–51.PubMedCrossRef Desamericq G, Tissot CM, Akakpo S, Tropeano AI, Millasseau S, Macquin-Mavier I. Carotid-femoral pulse wave velocity is not increased in obesity. Am J Hypertens. 2015;28(4):546–51.PubMedCrossRef
43.
44.
go back to reference Labouret G, Achimastos A, Benetos A, Safar M, Housset E. Systolic arterial hypertension in patients amputated for injury. Presse Med. 1983;12(21):1349–50.PubMed Labouret G, Achimastos A, Benetos A, Safar M, Housset E. Systolic arterial hypertension in patients amputated for injury. Presse Med. 1983;12(21):1349–50.PubMed
45.
go back to reference Jacomella V, Shenoy A, Mosimann K, Kohler MK, Amann-Vesti B, Husmann M. The impact of endovascular lower-limb revascularisation on the aortic augmentation index in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2013;45(5):497–501.PubMedCrossRef Jacomella V, Shenoy A, Mosimann K, Kohler MK, Amann-Vesti B, Husmann M. The impact of endovascular lower-limb revascularisation on the aortic augmentation index in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2013;45(5):497–501.PubMedCrossRef
46.
go back to reference Husmann M, Jacomella V, Thalhammer C, Amann-Vesti BR. Markers of arterial stiffness in peripheral arterial disease. Vasa. 2015;44(5):341–8.PubMedCrossRef Husmann M, Jacomella V, Thalhammer C, Amann-Vesti BR. Markers of arterial stiffness in peripheral arterial disease. Vasa. 2015;44(5):341–8.PubMedCrossRef
48.
go back to reference Cooper LL, Musani SK, Washington F, Moore J, Tripathi A, Tsao CW, et al. Relations of microvascular function, cardiovascular disease risk factors, and aortic stiffness in blacks: the Jackson Heart Study. J Am Heart Assoc. 2018;7(20):e009515.PubMedPubMedCentralCrossRef Cooper LL, Musani SK, Washington F, Moore J, Tripathi A, Tsao CW, et al. Relations of microvascular function, cardiovascular disease risk factors, and aortic stiffness in blacks: the Jackson Heart Study. J Am Heart Assoc. 2018;7(20):e009515.PubMedPubMedCentralCrossRef
49.
go back to reference Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997;30(7):1863–71.PubMedCrossRef Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997;30(7):1863–71.PubMedCrossRef
50.
go back to reference Nichols WW, Denardo SJ, Johnson BD, Sharaf BL, Bairey Merz CN, Pepine CJ. Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women’s Ischemia Syndrome Evaluation. J Hypertens. 2013;31(7):1447–54 (discussion 54–55).PubMedPubMedCentralCrossRef Nichols WW, Denardo SJ, Johnson BD, Sharaf BL, Bairey Merz CN, Pepine CJ. Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women’s Ischemia Syndrome Evaluation. J Hypertens. 2013;31(7):1447–54 (discussion 54–55).PubMedPubMedCentralCrossRef
51.
go back to reference Baldo MP, Cunha RS, Ribeiro ALP, Lotufo PA, Chor D, Barreto SM, et al. Racial differences in arterial stiffness are mainly determined by blood pressure levels: results from the ELSA-Brasil study. J Am Heart Assoc. 2017;6(6):e005477.PubMedPubMedCentralCrossRef Baldo MP, Cunha RS, Ribeiro ALP, Lotufo PA, Chor D, Barreto SM, et al. Racial differences in arterial stiffness are mainly determined by blood pressure levels: results from the ELSA-Brasil study. J Am Heart Assoc. 2017;6(6):e005477.PubMedPubMedCentralCrossRef
Metadata
Title
The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease
Authors
Nejc Piko
Sebastjan Bevc
Radovan Hojs
Franjo Husam Naji
Robert Ekart
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01859-0

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue